HCW Biologics Inc is trading 7.4% up at $1.30 in pre-market sessions, continuing a technical rebound following a sharp decline linked to share dilution.
- The stock's recovery follows investor concerns regarding a recent private placement, with today's price action extending the gains seen since June 10.
- While the broader market is showing strength, there are no new company-specific catalysts reported this morning to drive the move beyond technical factors.